Lyerly HK - Search Results

1

Ligand-independent toll-like receptor signals generated by ectopic overexpression of MyD88 generate local and systemic antitumor immunity.

Hartman ZC, Osada T, Glass O, Yang XY, Lei GJ, Lyerly HK, Clay TM. Hartman ZC, et al. Among authors: lyerly hk. Cancer Res. 2010 Sep 15;70(18):7209-20. doi: 10.1158/0008-5472.CAN-10-0905. Epub 2010 Sep 7. Cancer Res. 2010. PMID: 20823152 Free PMC article.

2

Immunotherapy of cancer using cytokine gene-modified tumor vaccines.

Gilboa E, Lyerly HK, Vieweg J, Saito S. Gilboa E, et al. Among authors: lyerly hk. Semin Cancer Biol. 1994 Dec;5(6):409-17. Semin Cancer Biol. 1994. PMID: 7703440 Review.

3

MAGE-1-specific precursor cytotoxic T-lymphocytes present among tumor-infiltrating lymphocytes from a patient with breast cancer: characterization and antigen-specific activation.

Toso JF, Oei C, Oshidari F, Tartaglia J, Paoletti E, Lyerly HK, Talib S, Weinhold KJ. Toso JF, et al. Among authors: lyerly hk. Cancer Res. 1996 Jan 1;56(1):16-20. Cancer Res. 1996. PMID: 8548758

4

Inhibition of established pancreatic cancers following specific active immunotherapy with interleukin-2 gene-transduced tumor cells.

Clary BM, Coveney EC, Philip R, Blazer DG 3rd, Morse M, Gilboa E, Lyerly HK. Clary BM, et al. Among authors: lyerly hk. Cancer Gene Ther. 1997 Mar-Apr;4(2):97-104. Cancer Gene Ther. 1997. PMID: 9080118

5

Active immunization with tumor cells transduced by a novel AAV plasmid-based gene delivery system.

Clary BM, Coveney EC, Blazer DG 3rd, Philip R, Philip M, Morse M, Gilboa E, Lyerly HK. Clary BM, et al. Among authors: lyerly hk. J Immunother. 1997 Jan;20(1):26-37. doi: 10.1097/00002371-199701000-00003. J Immunother. 1997. PMID: 9101411

6

Optimization of the sequence of antigen loading and CD40-ligand-induced maturation of dendritic cells.

Morse MA, Lyerly HK, Gilboa E, Thomas E, Nair SK. Morse MA, et al. Among authors: lyerly hk. Cancer Res. 1998 Jul 15;58(14):2965-8. Cancer Res. 1998. PMID: 9679955

7

Migration of human dendritic cells after injection in patients with metastatic malignancies.

Morse MA, Coleman RE, Akabani G, Niehaus N, Coleman D, Lyerly HK. Morse MA, et al. Among authors: lyerly hk. Cancer Res. 1999 Jan 1;59(1):56-8. Cancer Res. 1999. PMID: 9892184

8

Induction of carcinoembryonic antigen (CEA)-specific cytotoxic T-lymphocyte responses in vitro using autologous dendritic cells loaded with CEA peptide or CEA RNA in patients with metastatic malignancies expressing CEA.

Nair SK, Hull S, Coleman D, Gilboa E, Lyerly HK, Morse MA. Nair SK, et al. Among authors: lyerly hk. Int J Cancer. 1999 Jul 2;82(1):121-4. doi: 10.1002/(sici)1097-0215(19990702)82:1<121::aid-ijc20>3.0.co;2-x. Int J Cancer. 1999. PMID: 10360830

9

A Phase I study of active immunotherapy with carcinoembryonic antigen peptide (CAP-1)-pulsed, autologous human cultured dendritic cells in patients with metastatic malignancies expressing carcinoembryonic antigen.

Morse MA, Deng Y, Coleman D, Hull S, Kitrell-Fisher E, Nair S, Schlom J, Ryback ME, Lyerly HK. Morse MA, et al. Among authors: lyerly hk. Clin Cancer Res. 1999 Jun;5(6):1331-8. Clin Cancer Res. 1999. PMID: 10389916 Clinical Trial.

10

Induction of tumor immunity and cytotoxic T lymphocyte responses using dendritic cells transfected with messenger RNA amplified from tumor cells.

Boczkowski D, Nair SK, Nam JH, Lyerly HK, Gilboa E. Boczkowski D, et al. Among authors: lyerly hk. Cancer Res. 2000 Feb 15;60(4):1028-34. Cancer Res. 2000. PMID: 10706120

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

306 results

Search Page

Filters